Cyclooxygenase in epilepsy: from perception to application
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Chlamydia trachomatis serovars are divided into three serogroups, namely serogroup B, serogroup I (Intermediate) and serogroup C, and subsequently into 19 different serovars. Worldwide, serogroup B is the most prevalent followed by serogroup I. Clear differences have been observed in the duration of infection and growth kinetics between serovars from different serogroups in murine and cell culture models. Reasons for these observed differences are bacterial and host related, and are not well understood. The aim of this study was to determine the differences in immunoglobulin (Ig) G responses between the three serogroups in a group of patients infected with different serovars. Serovars were assessed from 235 C. trachomatispositive patients and quantitative IgG responses were determined. Analyses of variance were used to compare the IgG responses between the three serogroups. Of the serovars, 46% were B group (with serovar E the most prevalent: 35.3%), 39.6% were I group and 14.3% were C group. A highly significant difference in serologic response was shown when comparing the mean IgG concentrations (AU/mL) of patients having serovars in the most prevalent serogroup compared to the other serogroups: B = 135, C = 46 and I = 60 (B vs. C and B vs. I, P < 0.001). In conclusion, the most prevalent serovars generate the highest serologic responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manifestations and management of lymphogranuloma venereum.
White, J. A. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328320a8ae · Cited by 148 · cited 1×
“, men having sex with men [MSM] and small communities [7, 8]).”
Background
Cited by
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876
Epilepsy and brain inflammation
Vezzani, A., Aronica, E., Mazarati, A., & Pittman, Q. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.033 · Cited by 603
The role of inflammation in epileptogenesis
Vezzani, A., Friedman, A., & Dingledine, R. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.004 · Cited by 495
Vezzani, A., Maroso, M., Balosso, S., Sanchez, M.-A., & Bartfai, T. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.03.018 · Cited by 362
Contributions of peripheral inflammation to seizure susceptibility: Cytokines and brain excitability
Riazi, K., Galic, M. A., & Pittman, Q. J. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.09.004 · Cited by 306
Epilepsy and Inflammation in the Brain: Overview and Pathophysiology
Vezzani, A. (2014) · Epilepsy Currents · doi:10.5698/1535-7511-14.s2.3 · Cited by 208
Astrocyte immune responses in epilepsy
Aronica, E., Ravizza, T., Zurolo, E., & Vezzani, A. (2012) · Glia · doi:10.1002/glia.22312 · Cited by 207
“…event, a downstream cascade of inflammatory mediators is transcriptionally upregulated in brain tissue similar to what has been shown in human epilepsy [(De Simoni et al., 2000; Gorter et al., 2006; Vezzani et al., 1999, 2000); reviewed by (Kulkarni and Dhir, 2009; Vezzani et al., 2008a, 2011b)].”
BackgroundInflammation and prevention of epileptogenesis
Ravizza, T., Balosso, S., & Vezzani, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.040 · Cited by 199
Polascheck, N., Bankstahl, M., & Löscher, W. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.014 · Cited by 163
Metadata
- Authors
- Kulkarni, S. K., & Dhir, A.
- Venue
- Drugs of Today
- Publisher
- Portico
- Published
- 2009
- Volume
- 45
- Issue
- 2
- Pages
- 135
- ISSN
- 0025-7656 (ISSN-L)
- 1699-3993
- OpenAlex
- W1970423904
- Cited by
- 60
- References
- 1
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.